| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/28/2009 | WO2009023047A3 Methods for the directed expansion of epitopes for use as antibody ligands |
| 05/28/2009 | WO2008156713A3 Anti-cd20 therapeutic compositions and methods |
| 05/28/2009 | WO2008148926A3 Method for diagnosing immune system diseases and compounds that can be used to treat said diseases |
| 05/28/2009 | WO2008146164A3 Streptococcus pneumoniae pilus antigens |
| 05/28/2009 | WO2008145129A3 Influenza vaccines |
| 05/28/2009 | WO2008140542A3 Methods to decrease the risk of metabolic syndrome post immunization |
| 05/28/2009 | WO2008051980A8 Methods of reducing phosphate absorption |
| 05/28/2009 | WO2008051977A8 Methods of reducing phosphate absorption |
| 05/28/2009 | WO2007067596A3 Methods and compositions for needleless delivery of antibodies |
| 05/28/2009 | WO2006132966A3 Webbed hiv envelope immunogens, methods for production and use of same |
| 05/28/2009 | WO2006029248A3 Hollow fiber technique for in vivo study of cell populations |
| 05/28/2009 | WO2005084314A3 Audioligical treatment system and methods of using the same |
| 05/28/2009 | WO2005016238A3 Severe acute respiratory syndrome |
| 05/28/2009 | US20090138977 Pancreatic cancer targets and uses thereof |
| 05/28/2009 | US20090137788 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 05/28/2009 | US20090137787 Janus family kinases and identification of immune modulators |
| 05/28/2009 | US20090137782 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
| 05/28/2009 | US20090137778 A HIV peptide consisting of 23 to 50 amino acid residues; trans-activator |
| 05/28/2009 | US20090137464 Therapeutic fibrin-derived peptides and uses thereof |
| 05/28/2009 | US20090137412 Chromogenic in situ hybridization methods, kits, and compositions |
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090137002 Anti ephb4 antibodies and antibody fragments |
| 05/28/2009 | US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136969 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 05/28/2009 | US20090136939 Methods for diagnosis and therapy for pancreatic cancer and composition useful therein |
| 05/28/2009 | US20090136928 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 05/28/2009 | US20090136623 Growth inhibitory composition against pathogenic bacteria of meat based food stuff comprising igy |
| 05/28/2009 | US20090136572 Emulsified composition for dilution and cancer vaccine composition |
| 05/28/2009 | US20090136567 Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic Escherichia Coli |
| 05/28/2009 | US20090136548 Multiple antigenic peptides immunogenic against streptococcus pneumonia |
| 05/28/2009 | US20090136547 Zwitterionization of capsular saccharides |
| 05/28/2009 | US20090136546 Immunomodulating compositions and uses therefor |
| 05/28/2009 | US20090136545 Porcine rotavirus reassortant compositions |
| 05/28/2009 | US20090136544 Interfering RNAs Targeting the Morbillivirus Nucleoprotein Gene |
| 05/28/2009 | US20090136543 Vaccine |
| 05/28/2009 | US20090136542 Immunogenic composition and method of developing a vaccine based on portions of the HIV matrix protein |
| 05/28/2009 | US20090136541 Immunogenic composition |
| 05/28/2009 | US20090136538 Stable vaccine formulation |
| 05/28/2009 | US20090136537 Lipopeptide compositions and methods of use therof |
| 05/28/2009 | US20090136536 Recombinant Subunit Vaccine |
| 05/28/2009 | US20090136535 useful for enhancing immune response to antigens; lack ganglioside binding activity; applicable to mucosal immunization in humans |
| 05/28/2009 | US20090136534 A recombinant Bacille Calmette-Guerin (BCG) subunit-based vaccine in which Mtb antigens and Mtb resuscitation or reactivation antigens are overexpressed, and a portion of the DosR regulon is up-regulated; prevent establishment of latent TB or reactivated disease in adolescents/adults |
| 05/28/2009 | US20090136533 POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL |
| 05/28/2009 | US20090136532 Vaccine for Avian Influenza and Methods of Use |
| 05/28/2009 | US20090136531 HPV E6 protein T cell epitopes and uses thereof |
| 05/28/2009 | US20090136530 Influenza Hemagglutinin and Neuraminidase Variants |
| 05/28/2009 | US20090136529 Compositions And Methods For Treatment, Research And Therapeutic Applications For Malaria |
| 05/28/2009 | US20090136528 Novel immunogenic epitope for immunotherapy |
| 05/28/2009 | US20090136527 Synthetic peptide comprising the amino acid sequence GPRLGYSWHX in which each of the amino acids are in the D-amino acid configuration and X is any amino acid; optionally conjugated to the natural gonadotropin-releasing hormone peptide; vaccines for use incontrolling fertility or heat in an animal |
| 05/28/2009 | US20090136526 CD19 Binding Agents and Uses Thereof |
| 05/28/2009 | US20090136525 Immunoglobulins Comprising Predominantly a Glcnacman3Glcnac2 Glycoform |
| 05/28/2009 | US20090136524 Compositions and methods for diagnosis and treatment of tumors |
| 05/28/2009 | US20090136523 Anti-cd26 antibodies and methods of use thereof |
| 05/28/2009 | US20090136522 Multivalent Immunogen |
| 05/28/2009 | US20090136521 Method for Selectively Depleting Hypoxic Cells |
| 05/28/2009 | US20090136520 Mitochondrial localization of muc1 |
| 05/28/2009 | US20090136519 Tissue Protective Cytokine Receptor Complex, Assays for Identifying Tissue Protective Compounds and Uses Thereof |
| 05/28/2009 | US20090136518 Compositions and methods to reduce mutagenesis |
| 05/28/2009 | US20090136517 Combined treatment with an egfr kinase inhibitor and an inhibitor of c-kit |
| 05/28/2009 | US20090136516 Cd-20 specific antibodies and methods of employing same |
| 05/28/2009 | US20090136515 Methods of diagnosing, preventing and treating infection with Hepatitis C virus |
| 05/28/2009 | US20090136514 Tetracyclines for Treating Ocular Diseases and Disorders |
| 05/28/2009 | US20090136513 Bicyclo-pyrazoles active as kinase inhibitors |
| 05/28/2009 | US20090136512 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
| 05/28/2009 | US20090136511 an oligopeptide capable of binding cellular IL-15R alpha or its soluble fraction and inhibiting IL-15-dependent T cell proliferation activity, used for treating rheumatoid arthritis and psoriasis in a mammal; immunogens |
| 05/28/2009 | US20090136510 Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof |
| 05/28/2009 | US20090136509 Use of Toll-Like Receptor 4 Antagonists for the Treatment or Prevention of Osteoarthritic Conditions |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |
| 05/28/2009 | US20090136506 Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target |
| 05/28/2009 | US20090136505 Intranasal Administration of Active Agents to the Central Nervous System |
| 05/28/2009 | US20090136504 Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases |
| 05/28/2009 | US20090136503 Trail receptor-binding agents and uses of the same |
| 05/28/2009 | US20090136502 Preventives/Remedies for Cancer |
| 05/28/2009 | US20090136501 Compositions and methods for treating coagulation related disorders |
| 05/28/2009 | US20090136500 Humanized PAI-1 Antibodies |
| 05/28/2009 | US20090136499 RAF Inhibitors and Uses Thereof |
| 05/28/2009 | US20090136498 Method for Manufacturing Recombinant Polyclonal Proteins |
| 05/28/2009 | US20090136497 Methods for inhibiting cutaneous inflammation and hyperpigmentation |
| 05/28/2009 | US20090136496 Chronic lymphocytic leukemia prognosis and treatment |
| 05/28/2009 | US20090136495 useful therapeutically for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and/or hematocrit in a human; anemia |
| 05/28/2009 | US20090136494 Combination therapies employing GITR binding molecules |
| 05/28/2009 | US20090136493 Modified fusion molecules for treatment of allergic disease |
| 05/28/2009 | US20090136492 Therapy of ocular disorders |
| 05/28/2009 | US20090136491 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/28/2009 | US20090136490 Ovr110 antibody compositions and methods for use |
| 05/28/2009 | US20090136489 Methods for the treatment, diagnosis, and prognosis of cancer |
| 05/28/2009 | US20090136488 Inhibition of cancer metastasis |
| 05/28/2009 | US20090136487 Bmx mediated signal transduction in irradiated vascular endothelium |
| 05/28/2009 | US20090136486 Biomarkers for human papilloma virus-associated cancer |
| 05/28/2009 | US20090136485 Methods and compositions for inhibiting CD32B expressing cells |
| 05/28/2009 | US20090136484 Novel antibody molecules and nucleic acids |
| 05/28/2009 | US20090136483 Compositions and Methods for Binding Lysophosphatidic Acid |
| 05/28/2009 | US20090136482 Drug target protein and target gene, and screening method |
| 05/28/2009 | US20090136481 Use of Myostatin (GDF-8) Antagonists for Treatment of Sarcopenia (Age-Related Muscle-Wasting) |
| 05/28/2009 | US20090136480 Transcutaneous immunostimulation |
| 05/28/2009 | US20090136479 Ubiquitin-like protein isg15 for hiv inhibition |
| 05/28/2009 | US20090136462 Peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen, Prostate acid phosphatase and Prostate specific membrane antigen, BA-46, Mucin, and Teratocarcinoma-derived growth factor; bladder, prostate and breast cancers; antimetastasis agents |